Sep. 11 at 1:37 PM
$CYCU 👀🔥 Why I'm still BULLISH:
💰
$54.6M 10-year contract — expected
$5M+ annual recurring revenue starting in November
📈 ~
$30M estimated annual revenue run rate
🤖 NEW ~
$800K annual contract spend including a pharmaceutical AI Center of Excellence + NACCHO/public-health work
💵 Digital Ally Video Solutions acquisition adds
$5M+ revenue &
$1.2M+ EBITDA
📊 Q2 gross margin jumped to 29.1% vs 6.1% last year
💰 Net debt down 28% YoY
🔥
$500K share buyback authorized
🚨 BIG WILDCARD: Nasdaq hearing decision remains pending. A favorable ruling could remove a major cloud hanging over CYCU.
And today's premarket volume is already showing some early interest.
Contracts + AI/cybersecurity growth + improving margins + acquisitions + potential Nasdaq catalyst.
At these beaten-down levels,
$CYCU remains high on my watchlist. 👀🔥
NFA/DD.